Evidence map›Paper›PMID 34559984›Full record

ArticleCell2021

Closing the Rift: Discovery of a novel virus receptor.

Nathen E Bopp, Diana Fernández, Patricia V Aguilar

Abstract readComment
PubMed Publisher
In one paragraph

Article in Cell, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Nathen E BoppDepartment of Pathology, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77550, USA; Institute for Human Infection and Immunity, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77550, USA.
Diana FernándezDepartment of Pathology, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77550, USA; Institute for Human Infection and Immunity, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77550, USA; Center for Tropical Diseases, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77550, USA.
Patricia V AguilarDepartment of Pathology, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77550, USA; Institute for Human Infection and Immunity, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77550, USA; Center for Tropical Diseases, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77550, USA. Electronic address: pvaguila@utmb.edu.
The University of Texas Medical Branch at Galveston · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this issue of Cell, Ganaie et al. reports the identification of LRP1 as a receptor of the highly pathogenic Rift Valley fever virus. By using genome-wide CRISPR-Cas9 screening and functional studies, Ganaie et al. identified LRP1 and several co-factors as essential elements for virus infection.

Indexed as

Rift Valley FeverRift Valley fever virusAnimalsReceptors, VirusReceptors, Virus

Identifiers

PMID34559984
OpenAlexW3198975404

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.